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Summary 
The protein phosphatase  1 and 2A inhibitor,  okadaic acid,  has been shown to stimulate many 
cellular functions by increasing the phosphorylation state of phosphoproteins. In human monocytes, 
okadaic acid by itself stimulates  tumor necrosis factor c~ (TNF-c~) mRNA accumulation  and 
TNF-c~ synthesis.  Calyculin A,  a more potent inhibitor  of phosphatase  1,  has  similar effects. 
TNF-ol mRNA accumulation in okadaic acid-treated monocytes is due to increased TNF-cr mRNA 
stability and transcription  rate.  The increase in TNF-c~ mRNA stability is more remarkable in 
okadaic acid-treated monocytes than the mRNA stability of other cytokines, such as interleukin 
lot (Iblc~), IL-lf3, and IL-6.  Gel retardation  studies show the stimulation  of AP-1, AP-2,  and 
NF-~cB binding activities in okadaic acid-stimulated monocytes. This increase may correlate with 
the increase in TNF-ot mRNA transcription rate. In addition to the stimulation of TNF-ot secretion 
by monocytes, okadaic acid appears to modulate TNF-c~ precursor processing,  as indicated by 
a marked increase in the cell-associated 26-kD precursor. These results suggest that active basal 
phosphorylation/dephosphorylation  occurs in monocytes, and that protein phosphatase 1 or 2A 
is important in regulating TNF-c~ gene transcription,  translation,  and posttranslational  modification. 
T 
NF-ot has been shown to play important roles in many 
inflammatory and pathological conditions, as well as in 
cellular activation and differentiation (reviewed in reference 
1). The regulation of TNF-o~ production occurs at both trans- 
lational and transcriptional  levels. At the level of transcrip- 
tion, transcription factors NF-gB and AP-1 have been impli- 
cated in the activation of the TNF-c~ gene by LPS and PMA 
(2-5). Evidence has accumulated showing that the phosphory- 
lation states of NFgB-associated proteins influence the activity 
of NFKB (6, 7). Similarly, the phosphorylation state of c-jun 
is related to the activation of AP-1 (8, 9). Activation of NF- 
KB and AP-1 involves serine/threonine phosphorylation. The 
investigation of the roles of protein serine/threonine  phos- 
phatases in cellular processes has been facilitated by the avail- 
ability of inhibitors such as okadaic acid and calyculin A (10). 
Of relevance is the finding that okadaic acid has been shown 
to induce AP-1 and NF-gB in human T cells (11, 12). In the 
present study, these inhibitors are used to show that TNF-o~ 
gene transcription and production are induced in resting mono- 
cytes by the inhibition  of protein phosphatases. 
Materials and Methods 
Reagents and Cells.  Okadaic acid and calyculin A were from 
Moana Bioproducts (Honolulu,  HI). The sources of other reagents 
have been described (5,  13). Rabbit anti-TNF-c~ antibody was a 
gift of Dr. EdwardJeffes III (University of California, Irvine, CA). 
Human peripheral blood monocytes were isolated from buffy coats 
(Richmond Metropolitan Blood Service, Richmond, VA) by FicoU- 
Hypaque centrifugation,  E-rosette cell depletion of T  cells, and 
PercoU gradient centrifugation.  Cell culture reagents were <0.002 
ng/ml endotoxin (13). Monocyte preparations contained 90-95% 
monocytes, as shown by nonspecific esterase staining, and 95% of 
the cells were viable at the end of the experiments by trypan blue 
exclusion. 
Northern Blots, Nuclear Run-on, and mRNA  Stability Measure- 
ments.  Isolation of total KNA by ultracentrifugation  over a CsC1 
cushion and Northern blot hybridization procedures with cDNA 
of TNF-c~, Ibla, IL-1/~, c-jun,/~-actin, and the 26-mer 28S rKNA 
oligonucleotide probes have been described (13). The I1.,6 cDNA 
probe was a kind gift of Dr.  Pravin Sehgal (New York Medical 
College, Valhalh, NY). Blots were exposed multiple times and ex- 
posures within the linear range were scanned for absorbance. Nu- 
clear run-on assays were performed essentially as described, using 
15-25  x  106 nuclei per reaction (13). TNF-c~ nascent mlLNA was 
detected with a 234-bp PvulI fragment. For mtLNA stability studies, 
monocytes at 5  x  l@/ml were preincubated in 500 ng/ml LPS 
or 100 ng/ml okadaic acid for 2 h. Actinomycin D was then added 
to make the final concentration  10 i~g/ml. Samples were quickly 
cooled in three to four volumes ice-cold PBS at the indicated time 
points. RNA extraction and Northern blots were then performed. 
Gel Retardation Assays.  Nuclear extracts were prepared and gel 
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AP-2, and KB-2 of TNF-ot, and the myoD 48-bp oligonucleotide 
as described  (5). The tcB-3  oligonucleotide 5'-GAT CGA GCT CAT 
GGG TTT CTC CAC CAA GGA AG (4) and its complementary 
strand were used. 
Immunoprecipitation.  Labeling,  immunoprecipitation,  and gel 
analysis were performed according to the procedures described pre- 
viously (13). Cysteine-free medium and [3sS]cysteine  (50/zCi/ml, 
1,000 Ci/mmol; NEN/DuPont, Wilmington, DE) were used in- 
stead because of the lack of methionine  residues in the mature 
TNF-ot. Monocytes were incubated in labeling solutions containing 
various stimulants at 5  x  l& ceUs/ml (15-20  x  l& cellsAample) 
for 6 h. 
Results and Discussion 
Induction of TNF-ol mRNA by Phosphatase lnbibitors.  Fresh- 
ly isolated human peripheral blood monocytes were found 
to have little TNF-ot mRNA.  Okadaic acid was shown to 
be a potent inducer for TNF-a mRNA accumulation (Fig. 
1). This induction was dose dependent in the range of 10-100 
ng/ml, and occurred maximally 2-4 h after stimulation (data 
not shown). In some experiments, monocyte viability began 
to decline in 4-h cultures when 100 ng/ml okadaic acid was 
used. The okadaic acid effect was not due to endotoxin con- 
tamination. Polymyxin  B at 100 #g/ml inhibited 80% of the 
LPS effect and did not affect okadaic acid-mediated mRNA 
accumulation. Okadaic acid was synergistic with a subop- 
timal dose of LPS in the induction of TNF-a mRNA ac- 
cumulation (Fig. 1 A). Similar effects were observed regarding 
IL-1B mRNA accumulation. In contrast, minimal effects were 
observed in the case of Ibloe and IL-6. 
Calyculin A is a phosphatase inhibitor with a similar spec- 
trum of specificity as okadaic acid.  However, it is  10-100- 
fold more potent than okadaic acid in inhibiting phosphatase 
1, although it inhibits phosphatase 2A with similar potency 
(10).  Calyculin A,  at  10  and  30  ng/ml,  induced  TNF-a 
mRNA accumulation (Fig. 1/3). However, this inductive effect 
was not observed at a higher concentration of 100 ng/ml. 
Calyculin A at 10 ng/ml was markedly synergistic with LPS 
(Fig. 1 B). At 30 ng/ml, the synergism was less. At 100 ng/ml, 
calyculin A appeared to inhibit LPS-induced TNF-c~ mRNA 
accumulation.  These results indicate that phosphatases are 
important in the regulation of TNF-c~ mRNA accumulation. 
Previous studies  show  that  elevation of cAMP  inhibits 
TNF-ot mRNA expression induced by PMA or LPS (14). 
This inhibition is postulated to be due to the interaction of 
cAMP-responsive element binding proteins with the cAMP- 
responsive dement present at the -107 position of  the TNF-ot 
gene. Okadaic acid did not override this inhibitory effect (data 
not shown). Thus, serine/threonine phosphorylation regu- 
lated by phosphatase 1 and 2A and their regulatory phospha- 
tase may play a minor role in this process.  The addition of 
1-10/zg/ml of cycloheximide enhanced the okadaic acid and 
LPS effects. This superinduction is similar to TNF-ot mRNA 
induction by PMA in cell lines (reviewed in reference 1). Fur- 
thermore, de novo protein synthesis is not required. 
Effects of Okadaic Acid on TNF-oe mRNA Stability and Tran- 
scription Rate.  The induction of TNF-ot mRNA accumula- 
Figure 1.  Okadaic  acid (A) and calyculin  A (B) stimulation  ofcytokine 
mRNA expression  in human monocytes.  Freshly  isolated  monocytes  were 
incubated with control  medium (C) or medium containing  the indicated 
stimulants for 2 h. Northern blot assays were carried out. LPS (L) was 
used at 100 ng/ml. The concentrations  of okadaic acid (OA) were from 
I to 100 ng/ml and calyculin  A from 10 to 100 ng/ml as indicated. Mono- 
cytes in A and B were from different  individuals, and 15  x  106 cells were 
used in each sample. The result is representative  of three experiments. 
Figure 2.  Comparison  of TNF-c~ and IL-lc~ mRNA decay  in mono- 
cytes  stimulated  with LPS and okadaic  acid. Monocytes  were  preincubated 
in LPS (lanes I-4) or 100 ng/ml okadaic acid (OA; lanes 5-8) for 2 h. 
At the indicated time points after the addition of 10/~g/ml actinomycin 
D, RNA were extracted  and analyzed  by Northern blot. The absorbance 
of  TNF-o~  or IL-lc~  bands were  measured  by densitometry  and normalized 
against that of  28S rRNA bands. The normalized  absorbance  values  were 
plotted in a semilogarithmic  plot as percent of the zero-time  absorbance. 
The curves  were  fitted  by linear  regression  by the computer  software  pro- 
gram SigmaPlot. mRNA decay  curves in LPS are in open symbols for 
LPS and in closed symbols  for okadaic  acid. Decays  for TNF-c~  mRNA 
are in circles, and the decay for IL-l~x mRNA is shown in triangles. 
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acid. Monocytes (25  x  106Aample) were treated with control medium, 
or medium containing 100 ng/ml LPS, 100 ng/ml okadaic acid (OA), or 
100 ng/ml each of LPS and okadaic acid for 2 h at 5  x  106/ml.  Nuclei 
were isolated and labelled.  Nascent  mRNA  was run  off the template 
using 250/~CiAample ~-[32p]UTP  (3,000 Ci/mmol). The absorbance of 
TNF-c~ and c-jun mRNA signals in A were scanned by densitometty and 
normalized against that of B-actin. This relative absorbance is plotted in B. 
([]) Control; ([]) LPS; ([]) okadaic acid; and (~) LPS plus okadaic acid. 
tion by okadaic acid may be due to increases in mKNA sta- 
bility and/or increased transcription rate.  TNF-ot mKNA 
stabilization is particularly pertinent in this case, in view of 
the short half-life of TNF-ot mRNA and the increase of 
mRNA stability by protein kinase C (PKC) activation (5, 15). 
Since fleshly isolated monocytes have very little TNF-o~ 
mRNA, the half-life of TNF-c~ mRNA in LPS-stimulated 
monocytes  is used as a reference point. Thus, monocytes  were 
incubated with okadaic acid or LPS. Actinomycin D was added 
to inhibit transcription and mRNA decay was then measured. 
As shown in Fig. 2, TNF-c~ mRNA decayed rapidly in LPS- 
treated cells, with a t,~ of 17 min. In the okadaic acid-treated 
cells, the t,,~ of TNF-ol mRNA was lengthened to 35 min. 
In contrast to TNF-ot mRNA, Iblo~ mRNA has a slightly 
longer  t,,~ in  LPS-treated  monocytes.  The  occurrence  of 
doublets in Iblo~ mRNA in actinomycin  D-treated cultures 
may be due to processing of the poly(A) tail (16). Although 
not shown, the stability of the mRNA of other cytokines 
such as IL-lfl and II.-6 was not substantially different in the 
LPS- and okadaic acid-treated cells. Similar results were ob- 
tained in two additional experiments. Recently, a 32-kD pro- 
tein was described to bind the AU-rich Y-untranslated re- 
gion of certain  cytokine and oncogene mRNA,  and this 
binding was thought to be related to mRNA stability (17). 
Of more relevance is  the work by Bohjanen  et  al.  (18), 
describing  a PMA-regulated  32-kD protein binding to the 
AU-rich domain of  TNF-cr  but not c-myc mRNA. Whether 
Figure 4.  Stimulation of AP-1, AP-2, and NF-KB binding activities by 
okadaic acid. Gel mobility  shift assay  was performed as descn2~ed  in Materials 
and Methods using 10/~g of nuclear extract per assay. In A, the extracts 
were from monocytes in control medium (lanes I), in medium containing 
100 ng/ml LPS (lanes 2), 100 ng/ml okadaic acid (lanes 3), or LPS plus 
okadaic acid (lanes 4). Similar results were obtained in two additional ex- 
periments. In B, the specifidty of the retarded bands were examined by 
a binding competition assay. Nuclear extracts were incubated with 100- 
fold excess of the cold competitors for 10 min before the addition of AP-1, 
AP-2, and gB-2 probes. No extract was present in samples depicted in 
lanes I, 5, and 9.  MyoD (48 bp) and Ib2R gB (50 bp) (Tac gB) have 
been described (5). In the case of the cold ~B-3 probe. The inhibition was 
,070% by scanning. Arrows in both panels indicate sl~'ific retarded bands. 
Similar results were obtained in one additional experiment. 
this  protein is involved in the preferential  stabilization  of 
TNF-c~ mlLNA by okadaic acid remains to be determined. 
The effect of okadaic acid on TNF-c~ transcription was 
examined by nuclear run-on. A representative result of four 
experiments is depicted in Fig. 3. In this experiment, both 
LPS and okadaic acid increased the transcription  rate of the 
TNF-ot gene. In addition,  some additive effect was observed 
when both reagents were used. Although not shown, okadaic 
acid induced the accumulation of c-jun  mKNA. Thus, the 
transcription rate of  c-jun was included in Fig. 3. Indeed, the 
transcription rate for the c-jun  gene was enhanced by both 
LPS and okadaic add. However, there was no additive effect 
when both were included in the same culture. In experiments 
by gel retardation assays, there was an increase  in NF~B, AP-1, 
and AP-2 binding activities in nuclear extracts of monocytes 
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acid. TNF-c~  was immunoprecipitated from monocyte pellets (A) and cell 
supematants (B). The monocytes (20  x  106/ml) were incubated in con- 
trol medium (lane I), 100 ng/ml LPS (lane 2), 50 ng/ml okadaic acid (lane 
3), or 100 ng/ml LPS plus 50 ng/ml okadaic acid (lane 4) for 6 h. 26- 
and 17-kD markers indicate precursor and mature TNF-ot. The 60-kD 
band of uncertain significance  was markedly increased  in okadaic acid cul- 
tures. A representative of three experiments is described. 
treated with either LPS or okadaic  acid (Fig.  4 A).  These 
binding activities were specific as they could only be inhibited 
by specific probes (Fig.  4 B). Similar  results  were obtained 
for both KB-2 and gB-3 binding sites (4), although only the 
data for the KB-2 binding site were presented. Higher binding 
activities were observed consistently in the nuclear extracts 
of monocytes treated with both LPS and okadaic acid. The 
increase in these DNA binding activities may in part account 
for the observed increase  in transcription rate for TNF-ot 
mRNA. Thus, both increase in mRNA stability and increased 
transcription rate contribute to the accumulation of TNF-c~ 
mRNA induced by okadaic  acid. 
Increase in  TNF-cr Production Induced by  Oleadaic Acid. 
TNF-ot production has been shown to be under translational 
control (1). The possibility for the involvement of phospha- 
tases  1 and 2A in  this process  was investigated.  Okadaic 
acid-stimulated monocytes were metabolically labeled with 
[3SS]cysteine. Because of the length of incubation of 6 h and 
the toxicity of okadaic acid, a reduced dose of 50 ng/ml was 
used. Both the supernatant and the ceU pellet were examined 
for TNF-oz production by immunoprecipitation. As shown 
in Fig. 5, there was little TNF-c~ production in the control 
culture. LPS stimulated TNF-oz production, as evidenced by 
the precipitated bands in both the supernatant and cell pellet. 
Okadaic acid was more potent in its induction of TNF-oe 
secretion and it was synergistic with LPS in this stimulation. 
It is of interest to note that the 26-kD TNF-c~ precursor form 
was more prominent in okadaic acid-stimulated, but not in 
LPS-stimulated, cells. This 26-kD precursor form has been 
detected to be cell associated (19). In this regard, monocytes 
stimulated with okadaic acid were stained with two blocking 
anti-TNF-ot mAbs. No surface staining was detected. Thus, 
the majority of precursor TNF-c~ may not be expressed on 
the surface of these stimulated cells. These results would im- 
plicate phosphatase I and 2A in playing a role in translational 
and posttranslational modification of TNF-ot. 
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